Indresh Srivastava, Ph.D., To Give A Featured Presentation At The 5th Biological Therapeutics Conference Oct 20-22, San Francisco, CA

Indresh Srivastava, Ph.D., Head of Protein Biology, Novartis, will give a featured presentation at the 5th Biological Therapeutics Research and Development Conference to be held in San Francisco, CA on Oct. 20-22, 2010 by GTCbio as part of the 6th Annual Modern Drug Discovery and Development Summit. The conference provides its participants with a current look at biologics and projects into its future with discussions regarding developments and challenges in immunogenicity, humanization, drug delivery techniques for biologics, modern vaccine development, antibodies, and novel protein and peptide delivery. Overcoming the issue of the role of biologics in drug discovery and how to improve upon the length of time a drug remains effective in the body, without losing money, will be addressed.



Also presenting at the 5th Biological Therapeutics Conference are prestigious organizations including Abbott, Amgen, Albany Medical Center, Auburn University, Facet Biotech, subsidiary of Abbott Labs, Genentech, Novartis, NCI, NIH, MedImmune, UCSF, Transgene, Micromet, Amunix, Nektar, Bayhill Therapeutics, and other leaders in the industry.



Author:

GTCbio



Source:

GTCbio

434 W. Foothill Blvd. Monrovia, CA 91016

Tel: (626) 256-6405

fax: (626) 256-6460

email: infogtcbiogtcbio



Company Website



Event Website